Xilio Therapeutics reported a net margin of -18.68% for the quarter ended Jun 2026. These financial ratios cover 23 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2020 | Dec2020 | Mar2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||
| EBT Margin | -623.84% | -652.32% | -790.55% | -472.73% | -177.71% | -10.12% | -86.48% | -111.57% | -18.68% | ||||||||||||||
| EBIT Margin | -623.84% | -652.32% | -790.55% | -472.73% | -177.71% | -10.12% | -86.48% | -111.57% | -18.68% | ||||||||||||||
| EBITDA Margin | -623.84% | -652.32% | -790.55% | -472.73% | -177.71% | -10.12% | -86.48% | -111.57% | -18.68% | ||||||||||||||
| Operating Margin | -623.84% | -652.32% | -790.55% | -472.73% | -177.71% | -10.12% | -86.48% | -111.57% | -18.68% | ||||||||||||||
| Net Margin | -623.84% | -652.32% | -790.55% | -472.73% | -177.71% | -10.12% | -86.48% | -111.57% | -18.68% | ||||||||||||||
| FCF Margin | 846.54% | -604.55% | -821.52% | 979.04% | -180.70% | -91.76% | -15.29% | -181.05% | -100.48% | ||||||||||||||
| Efficiency | |||||||||||||||||||||||
| Assets AverageAssets Avg. | 169.39M | 207.21M | 187.24M | 167.77M | 148.29M | 125.33M | 101.93M | 85.10M | 69.38M | 71.77M | 86.24M | 82.27M | 72.87M | 87.40M | 118.76M | 133.75M | 144.19M | 159.09M | 158.87M | ||||
| Invested CapitalInvested Cap. | -126.88M | 195.06M | 175.80M | 153.94M | 136.08M | 115.48M | 93.01M | 74.52M | 57.45M | 40.14M | |||||||||||||
| Asset Utilization RatioAsset Util. | 0.11 | 0.13 | 0.24 | 0.30 | 0.34 | 0.40 | |||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -55.04 | -112.39 | -164.53 | ||||||||||||||||||||
| Debt Ratio | 0.08 | 0.04 | 0.05 | 0.05 | 0.06 | 0.07 | 0.07 | 0.08 | 0.06 | 0.05 | |||||||||||||
| Times Interest Earned | -55.04 | -112.39 | -164.53 | ||||||||||||||||||||
| Valuation | |||||||||||||||||||||||
| Price to EarningsP/E | -4.55 | -9.06 | -3.26 | -3.95 | -3.18 | -3.70 | -3.58 | -3.35 | -0.84 | -1.72 | -3.72 | -3.39 | -3.21 | -3.91 | -4.56 | -62.96 | -6.33 | -9.74 | -53.25 | ||||
| Price to SalesP/S | 23.22 | 22.09 | 25.35 | 18.47 | 8.11 | 6.37 | 5.47 | 10.87 | 9.95 | ||||||||||||||
| Price to BookP/B | 0.48 | 1.17 | 0.55 | 0.63 | 0.70 | 1.03 | 1.07 | 1.11 | 0.41 | 1.17 | 1.64 | 2.38 | 2.48 | 5.06 | 9.28 | -15.00 | 2.12 | 1.90 | 2.57 | ||||
| Enterprise Value | -108.35M | 16.59M | -79.43M | -59.39M | -46.61M | -6.29M | -3.28M | -1.69M | -29.52M | -3.83M | -20.22M | -11.27M | -11.59M | -34.96M | -55.97M | 17.68M | -62.61M | -12.85M | 49.86M | ||||
| EV to EBIT | 5.54 | -0.78 | 3.24 | 2.94 | 2.01 | 0.27 | 0.16 | 0.10 | 1.63 | 0.22 | 1.38 | 0.76 | 0.85 | 2.52 | 3.90 | -9.16 | 5.29 | 0.91 | -14.28 | ||||
| EV to EBITDA | 5.54 | -0.78 | 3.24 | 2.94 | 2.01 | 0.27 | 0.16 | 0.10 | 1.63 | 0.22 | 1.38 | 0.76 | 0.85 | 2.52 | 3.90 | -9.16 | 5.29 | 0.91 | -14.28 | ||||
| Market Capitalization | 89.70M | 193.55M | 79.98M | 79.75M | 73.77M | 86.98M | 72.10M | 58.09M | 15.18M | 30.15M | 54.73M | 49.99M | 43.70M | 54.12M | 65.58M | 121.44M | 74.92M | 137.48M | 185.90M | ||||
| Price to FCFP/FCF | -5.11 | -9.18 | -4.56 | -3.94 | -3.94 | -3.40 | -4.30 | -4.34 | -1.13 | -2.86 | 2.74 | -3.65 | -3.09 | 1.89 | -4.49 | -6.94 | -35.80 | -6.00 | -9.90 | ||||
| EV to FCF | 6.18 | -0.79 | 4.53 | 2.93 | 2.49 | 0.25 | 0.20 | 0.13 | 2.20 | 0.36 | -1.01 | 0.82 | 0.82 | -1.22 | 3.83 | -1.01 | 29.91 | 0.56 | -2.65 | ||||
| EV to CFO | 6.31 | -0.80 | 4.74 | 2.98 | 2.56 | 0.25 | 0.20 | 0.13 | 2.20 | 0.37 | -1.01 | 0.82 | 0.82 | -1.21 | 3.87 | -1.01 | 31.34 | 0.58 | -2.66 | ||||
| Return Ratios | |||||||||||||||||||||||
| Return on Sales [ROS]ROS | -623.84% | -652.32% | -790.55% | -472.73% | -177.71% | -10.12% | -86.48% | -111.57% | -18.68% | ||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -47.92% | -40.90% | -47.97% | -56.67% | -70.10% | -83.79% | -101.61% | -123.47% | -148.11% | -181.89% | -142.19% | -147.10% | -132.84% | -143.23% | -86.42% | -56.59% | -47.75% | -36.38% | -25.16% | ||||
| Return on Assets [ROA]ROA | -44.66% | -38.77% | -43.73% | -51.17% | -60.21% | -72.97% | -85.37% | -98.91% | -114.05% | -101.85% | -78.48% | -79.11% | -83.14% | -65.16% | -47.66% | -32.73% | -29.12% | -26.55% | -19.74% |